Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target

Volume: 13, Issue: 1
Published: Feb 9, 2022
Abstract
A major rate-limiting step in developing more effective immunotherapies for GBM is our inadequate understanding of the cellular complexity and the molecular heterogeneity of immune infiltrates in gliomas. Here, we report an integrated analysis of 201,986 human glioma, immune, and other stromal cells at the single cell level. In doing so, we discover extensive spatial and molecular heterogeneity in immune infiltrates. We identify molecular...
Paper Details
Title
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
Published Date
Feb 9, 2022
Volume
13
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.